U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07420296) titled 'Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder' on Feb. 02.
Brief Summary: Study Title: A National, Multicenter, Randomized Controlled Trial of the Modified Zipper Therapy in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder (ELITE Study)
Brief Summary:
The goal of this clinical trial is to evaluate the efficacy and safety of a novel sequential immunomodulation strategy, termed "Modified Zipper Therapy," in patients with acute attacks of Aquaporin-4 antibody-positive Neuromyelitis Optica Spectrum Disorder (AQP4-IgG+ NMOSD). The therapy aims to enhance neurological recovery by combi...